FDA Inspection 675587 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567027

The FDA completed an inspection of Regenerative Biologics, Inc. on August 11, 2010 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 11, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Jacksonville, FL (United States)